グラム陽性菌感染症薬の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9101951）

◆英語タイトル：Global Gram-positive Bacterial Infection Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9101951
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：121
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、グラム陽性菌感染症薬の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、抗真菌剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。グラム陽性菌感染症薬の世界市場概観、企業動向、企業別グラム陽性菌感染症薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・グラム陽性菌感染症薬の市場概観
・グラム陽性菌感染症薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・グラム陽性菌感染症薬の企業別販売動向、市場シェア、市場集中度、競争動向
・グラム陽性菌感染症薬の世界市場規模
・グラム陽性菌感染症薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・グラム陽性菌感染症薬のアメリカ市場規模推移
・グラム陽性菌感染症薬のカナダ市場規模推移
・グラム陽性菌感染症薬のメキシコ市場規模推移
・グラム陽性菌感染症薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・グラム陽性菌感染症薬のドイツ市場規模推移
・グラム陽性菌感染症薬のイギリス市場規模推移
・グラム陽性菌感染症薬のロシア市場規模推移
・グラム陽性菌感染症薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・グラム陽性菌感染症薬の日本市場規模推移
・グラム陽性菌感染症薬の中国市場規模推移
・グラム陽性菌感染症薬の韓国市場規模推移
・グラム陽性菌感染症薬のインド市場規模推移
・グラム陽性菌感染症薬の東南アジア市場規模推移
・グラム陽性菌感染症薬の南米市場分析（ブラジル、アルゼンチン等）
・グラム陽性菌感染症薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・グラム陽性菌感染症薬の種類別分析/販売量、売上、市場シェア（抗生物質、抗真菌剤、その他）
・グラム陽性菌感染症薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・グラム陽性菌感染症薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・グラム陽性菌感染症薬の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.

Scope of the Report:
The global Gram-positive Bacterial Infection Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gram-positive Bacterial Infection Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Gram-positive Bacterial Infection Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gram-positive Bacterial Infection Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novartis
Merck
AstraZeneca
Allergan
Theravance Biopharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antibiotic
Antifungal
Others

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

1 Gram-positive Bacterial Infection Drugs Market Overview
1.1 Product Overview and Scope of Gram-positive Bacterial Infection Drugs
1.2 Classification of Gram-positive Bacterial Infection Drugs by Types
1.2.1 Global Gram-positive Bacterial Infection Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Types in 2018
1.2.3 Antibiotic
1.2.4 Antifungal
1.2.5 Others
1.3 Global Gram-positive Bacterial Infection Drugs Market by Application
1.3.1 Global Gram-positive Bacterial Infection Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gram-positive Bacterial Infection Drugs Market by Regions
1.4.1 Global Gram-positive Bacterial Infection Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Gram-positive Bacterial Infection Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gram-positive Bacterial Infection Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gram-positive Bacterial Infection Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Gram-positive Bacterial Infection Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gram-positive Bacterial Infection Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Gram-positive Bacterial Infection Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Allergan
2.9.1 Business Overview
2.9.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Allergan Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.10 Theravance Biopharma
2.10.1 Business Overview
2.10.2 Gram-positive Bacterial Infection Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Theravance Biopharma Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gram-positive Bacterial Infection Drugs Market Competition, by Players
3.1 Global Gram-positive Bacterial Infection Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Gram-positive Bacterial Infection Drugs Players Market Share
3.2.2 Top 10 Gram-positive Bacterial Infection Drugs Players Market Share
3.3 Market Competition Trend
4 Global Gram-positive Bacterial Infection Drugs Market Size by Regions
4.1 Global Gram-positive Bacterial Infection Drugs Revenue and Market Share by Regions
4.2 North America Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
5 North America Gram-positive Bacterial Infection Drugs Revenue by Countries
5.1 North America Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
5.2 USA Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
6 Europe Gram-positive Bacterial Infection Drugs Revenue by Countries
6.1 Europe Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
6.2 Germany Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
6.4 France Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Countries
7.1 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
7.2 China Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
7.5 India Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
8 South America Gram-positive Bacterial Infection Drugs Revenue by Countries
8.1 South America Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
8.2 Brazil Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Gram-positive Bacterial Infection Drugs by Countries
9.1 Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
10 Global Gram-positive Bacterial Infection Drugs Market Segment by Type
10.1 Global Gram-positive Bacterial Infection Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Gram-positive Bacterial Infection Drugs Market Forecast by Type (2019-2024)
10.3 Antibiotic Revenue Growth Rate (2014-2024)
10.4 Antifungal Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Gram-positive Bacterial Infection Drugs Market Segment by Application
11.1 Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Application (2014-2019)
11.2 Gram-positive Bacterial Infection Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2024)
12.1 Global Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2024)
12.2 Global Gram-positive Bacterial Infection Drugs Market Forecast by Regions (2019-2024)
12.3 North America Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
12.6 South America Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Gram-positive Bacterial Infection Drugs Picture
Table Product Specifications of Gram-positive Bacterial Infection Drugs
Table Global Gram-positive Bacterial Infection Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Types in 2018
Figure Antibiotic Picture
Figure Antifungal Picture
Figure Others Picture
Table Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Application (2014-2024)
Figure Gram-positive Bacterial Infection Drugs Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Gram-positive Bacterial Infection Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Gram-positive Bacterial Infection Drugs Type and Applications
Table Pfizer Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Gram-positive Bacterial Infection Drugs Type and Applications
Table Sanofi Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Gram-positive Bacterial Infection Drugs Type and Applications
Table GlaxoSmithKline Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Gram-positive Bacterial Infection Drugs Type and Applications
Table Bayer Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Type and Applications
Table Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gram-positive Bacterial Infection Drugs Type and Applications
Table Novartis Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gram-positive Bacterial Infection Drugs Type and Applications
Table Merck Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gram-positive Bacterial Infection Drugs Type and Applications
Table AstraZeneca Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Gram-positive Bacterial Infection Drugs Type and Applications
Table Allergan Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table Theravance Biopharma Gram-positive Bacterial Infection Drugs Type and Applications
Table Theravance Biopharma Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue Share by Players (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Share by Players in 2017
Figure Global Gram-positive Bacterial Infection Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Gram-positive Bacterial Infection Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Gram-positive Bacterial Infection Drugs Revenue Market Share in 2018
Figure Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Regions in 2018
Figure North America Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure South America Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Table North America Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
Table North America Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries in 2018
Figure USA Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Table Europe Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries in 2018
Figure Germany Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure UK Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure France Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries in 2018
Figure China Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure India Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Table South America Gram-positive Bacterial Infection Drugs Revenue by Countries (2014-2019)
Table South America Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries in 2018
Figure Brazil Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue Share by Type (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Share by Type (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Share by Type in 2019
Table Global Gram-positive Bacterial Infection Drugs Revenue Forecast by Type (2019-2024)
Figure Global Gram-positive Bacterial Infection Drugs Market Share Forecast by Type (2019-2024)
Figure Global Antibiotic Revenue Growth Rate (2014-2019)
Figure Global Antifungal Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue by Application (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Revenue Share by Application (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Share by Application (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Share by Application in 2019
Table Global Gram-positive Bacterial Infection Drugs Revenue Forecast by Application (2019-2024)
Figure Global Gram-positive Bacterial Infection Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Gram-positive Bacterial Infection Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
Figure Europe Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
Figure South America Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue Market Forecast (2019-2024)

【掲載企業】

Pfizer、Sanofi、GlaxoSmithKline、Bayer、Bristol-Myers Squibb、Novartis、Merck、AstraZeneca、Allergan、Theravance Biopharma、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ グラム陽性菌感染症薬の世界市場2019(Global Gram-positive Bacterial Infection Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp